NC3Rs/Safety Pharmacology Society regional meeting: The use of human tissues for safety assessment

  • NC3Rs
Wednesday 03 May 2017 10:00 to 16:30
Coventry, UK

The workshop, co-organised by the NC3Rs, SPS and Coventry University, aims to bring together researchers from academia, SMEs and the pharmaceutical industry to discuss how best to support and enable the use of human tissues in safety testing. The one-day workshop will be held in Coventry, UK on Wednesday 03 May 2017. The overall aims of the workshop are to: 

  • highlight scientific advances, model development and process changes since the NC3Rs/MHRA workshop on 'Human tissue in safety pharmacology' in 2014;
  • discuss the predictive value of these in vitro approaches as alternatives to animal models and integration into current and future testing strategies;
  • enrich the scientific education experience amongst scientists and students working in the field or related fields, and highlight benefits of SPS membership.

The workshop is part of a wider NC3Rs initiative to improve the predictive capacity and relevance of research models to human safety testing, and to implement human tissue as a replacement for animal models.


The programme consists of presentations, posters, exhibitors and networking opportunities.

Researchers from academia and industry will speak in three sessions:

  • supporting the use of human tissue and alternative approaches to animal studies;
  • regulatory perspectives and current progress towards human tissue acceptance;
  • highlighting new technologies. 

Confirmed speakers include: 

  • Professor Olivier Sparagano, Coventry University
  • Dr Will Redfern, AstraZeneca on behalf of the Safety Pharmacology Society
  • Dr Helen Prior, NC3Rs
  • Dr Brian Berridge, GlaxoSmithKline
  • Dr Mark Holbrook, Vast Pharma Solutions
  • Dr Sam Jackson, NC3Rs
  • Professor Helen Maddock, Coventry University
  • Dr Emma Lawrence, UKCRC Tissue Directory and Coordination Centre
  • Dr Michelle Beharry, Medicines and Healthcare Products Regulatory Agency
  • Dr Karlijn Wilschut, Mimetas
  • Dr Samantha Maitland, Asterand UK
  • Dr Mark Bryant, Clyde Biosciences
  • Dr Mayel Gharanei, InoCardia

The workshop will be chaired by Dr Rob Wallis, Safety Pharmacology Consultant.


There will be an opportunity to present a poster on relevant work highlighting the use of human tissues (donor tissues/organ or human stem-cell derived cultured cells), this includes work that may have been presented at previous SPS meeting. Please note, the space for posters is limited, so posters will be selected from submitted abstracts.  If you would like to present a poster at the meeting please complete and return the poster abstract form to by 12 April 2017. We will let you know if you have been successful by 19 April 2017.

Exhibitor opportunities:

We will be offering companies exhibitor space to facilitate greater awareness of the opportunities for accessing human tissue and for outsourcing human tissue-based safety testing. Exhibitor space will be limited, so we are asking potential exhibitors to complete and return the exhibitor abstract form. Completed forms should be submitted to by 12 April 2017. We will let you know if you have been successful by 19 April 2017.

There is no charge for exhibiting at the meeting.


Attendance is free but registration is essential. Registration closes on 14 April 2017.

You will need an NC3Rs website account to register. Please use your institutional email address when registering.


  • Please indicate if you are an SPS member.

Event status

Registration now closed